A citation-based method for searching scientific literature

Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella, Arthur P Grollman, Tong-Chuan He, Yiping He, Ralph H Hruban, George I Jallo, Nils Mandahl, Alan K Meeker, Fredrik Mertens, George J Netto, B Ahmed Rasheed, Gregory J Riggins, Thomas A Rosenquist, Mark Schiffman, Ie-Ming Shih, Dan Theodorescu, Michael S Torbenson, Victor E Velculescu, Tian-Li Wang, Nicolas Wentzensen, Laura D Wood, Ming Zhang, Roger E McLendon, Darell D Bigner, Kenneth W Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan. Proc Natl Acad Sci U S A 2013
Times Cited: 841



Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar, Rogier Versteeg. Nat Genet 2015
Times Cited: 180




List of shared articles



Times cited

A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
Sounak Gupta, Chad M Vanderbilt, Yun-Te Lin, Jamal K Benhamida, Achim A Jungbluth, Satshil Rana, Amir Momeni-Boroujeni, Jason C Chang, Tiffany Mcfarlane, Paulo Salazar,[...]. J Mol Diagn 2021
1

Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction.
Shalu Sharma, Ananda Kishore Mukherjee, Shuvra Shekhar Roy, Sulochana Bagri, Silje Lier, Meenakshi Verma, Antara Sengupta, Manish Kumar, Gaute Nesse, Deo Prakash Pandey,[...]. Cell Rep 2021
0

Cancer regulatory variation.
Rebecca C Hennessey, Kevin M Brown. Curr Opin Genet Dev 2021
0

Telomere-related Markers for Cancer.
Xiaotian Yuan, Mingkai Dai, Dawei Xu. Curr Top Med Chem 2020
10

TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
13

Regulation of human telomerase in homeostasis and disease.
Caitlin M Roake, Steven E Artandi. Nat Rev Mol Cell Biol 2020
42

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, Shawn J Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle,[...]. Cancer Res 2020
11